HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia.

AuthorsCédric Bretonnière, Cédric Jacqueline, Jocelyne Caillon, Christophe Guitton, Cyndie Desessard, Virginie Le Mabecque, Anne Françoise Miégeville, Daniel Villers, Gilles Potel, David Boutoille
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 67 Issue 3 Pg. 780-1 (Mar 2012) ISSN: 1460-2091 [Electronic] England
PMID22184470 (Publication Type: Comparative Study, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Carbapenems
  • Thienamycins
  • Imipenem
  • Doripenem
  • Meropenem
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage)
  • Bacterial Load
  • Carbapenems (administration & dosage)
  • Colony Count, Microbial
  • Disease Models, Animal
  • Doripenem
  • Humans
  • Imipenem (administration & dosage)
  • Lung (microbiology)
  • Meropenem
  • Pneumonia, Bacterial (drug therapy)
  • Pseudomonas Infections (drug therapy)
  • Pseudomonas aeruginosa (drug effects)
  • Rabbits
  • Thienamycins (administration & dosage)
  • Treatment Outcome
  • beta-Lactam Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: